Company Updates
Moroku Secures Topflight Tech leader as CTO
Moroku today announced that Rudi Engelbrecht will be joining Moroku as Chief Technology and Operations Officer
Rudi will be joining the company from Paradigm Global Solutions where he was the CEO
Geniusto International LTD completes its M&A of a leading European fintech platform developer
PERTH, AUSTRALIA – February 10, 2021 – Geniusto International LTD, the parent company of Geniusto Philippines Incorporated, announced that it has successfully acquired GCP Software UK, a banking
Biorithm featured in Medical Festival Asia 2020
Biorithm’s novel femom remote monitoring system was featured at the Medical Festival Asia in two panels discussing new technologies in healthcare and women’s health.
Moscar Capital announces investment into Diamond White Aligners
Moscar Capital are delighted to announce our investment into Diamond White Aligners (DWA). The company offers a cost-effective alternative to braces for straightening your teeth, with savings of up
Incomlend is offering investors yields via credit receivables (100% covered by credit insurance) with a 120 day maturity
“We’re a global online invoice trading platform that connects exporters and importers with world-class institutional investors. Investors can access an attractive new alternative asset class and
Inspirenine is launching a fashion-tech first with their latest platform, led by founders with a successful track record of app creation (30 apps launched, top 30 within 4 weeks)
“We are excited about helping everyone feel confident and being more of who they truly are! Our mission is for everyone to be confident inside and out by inspiring users with outfit ideas that suit
What is Secondary Sales?
Traditionally people have invested in companies through IPO listing or stock exchange. Buying shares in a company can be done, not necessarily through the stock exchange or being a founder or
S$11.4 million in revenue for Singapore-based FinEduTech company as of 1HFY2021, exceeding FY2020
Uniquely rooted in FinEduTech, investor learning is powered by technology at 8VI, where core principles of value investing are integrated onto a single VI platform.
Fiona Stanley Hospital Phase I/II Clinical Trial Evaluating Topical Spray-On Antibiotic RECCE® 327 on Chronic Burn Wounds
Sydney Australia, 16 February 2021: Recce Pharmaceuticals Ltd (ASX:RCE), the Company developing New Classes of Synthetic Anti-Infectives, today announced it has formalised an agreement with
Backed By Leading Investment Groups and Family Offices
